Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate

[News]

Mitomics, world leader in the research and development of mitochondrial genome-based products, today announced it has entered into a non-exclusive licensing agreement with QDx Pathology Services to develop, market and process the QPredict™ Prostate Mitomic Test.

More... (http://www.news-medical.net/news/20110519/Mitomics-enters-licensing-agreement-with-QDx-Pathology-Services-for-QPredict-Prostate-Mitomic-Test.aspx)